ACTIVE

MONA LISA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-83,4 k €

+85.9% YoY

Revenue

4,2 M €

+36.2% YoY

Equity

2 M €

-4.0% YoY

Workforce

9,7 ETP

+3.2% YoY

What does MONA LISA do?

MONA LISA is a Public limited company incorporated in 1995. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Herk-de-Stad. It employs on average 9,7 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0456.182.981

Incorporation

02/10/1995

Legal form

Public limited company

Registered office

Kapelstraat 1
3540 Herk-de-Stad · FlandreSee on map

Contributed capital

70 000,00 €

Latest accounts

31/12/2025

Average workforce

9,7 ETP

Activities (NACE)

32500Manufacture of medical and dental instruments and supplies· main 32500Manufacture of medical and dental instruments and supplies 33102Repair of fabricated metal products, machinery and equipment 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 51460Air transport+3

Joint committees (1)

Signals

Solid equityLow riskGood liquidityHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	4,2 M €	+36.2%	3,1 M €	-10.6%	3,4 M €	+11.0%	3,1 M €	+1.0%	3,1 M €	+18.3%	2,6 M €	+2.7%	2,5 M €	-6.3%	2,7 M €	+23.2%	2,2 M €	-20.7%	2,8 M €	+42.9%	1,9 M €	+12.7%	1,7 M €	-1.3%	1,7 M €	+14.6%	1,5 M €	+35.2%	1,1 M €	-17.1%	1,4 M €	+29.7%	1 M €	-4.5%	1,1 M €	+22.5%	891 k €	+48.6%	599,5 k €
EBITDA	-90,2 k €	+81.9%	-497,3 k €	-204%	477,4 k €	-16.0%	568 k €	-22.7%	734,5 k €	-0.6%	739,1 k €	+47.1%	502,4 k €	-34.6%	768,6 k €	+2.5%	749,9 k €	-32.4%	1,1 M €	+105%	540,9 k €	+6.1%	509,8 k €	+12.1%	454,8 k €	+18.4%	384,2 k €	+32.0%	291,1 k €	-41.5%	498 k €	+63.9%	303,9 k €	-25.9%	410,3 k €	+15.7%	354,7 k €	+107%	171,3 k €
Operating result	-83,6 k €	+85.1%	-561,1 k €	-236%	413,3 k €	-20.9%	522,5 k €	-25.0%	697,2 k €	-1.1%	704,7 k €	+58.7%	444,1 k €	-40.4%	745,7 k €	+1.1%	737,4 k €	-32.6%	1,1 M €	+107%	527,4 k €	+5.0%	502,3 k €	+10.2%	455,6 k €	+20.9%	377 k €	+29.4%	291,4 k €	-44.9%	528,7 k €	+78.8%	295,7 k €	-25.0%	394,3 k €	+22.0%	323,2 k €	+124%	144,6 k €
Net result	-83,4 k €	+85.9%	-591,4 k €	-311%	280,8 k €	-22.8%	363,6 k €	-26.5%	494,4 k €	-2.4%	506,4 k €	+74.0%	291 k €	-42.6%	507 k €	+7.5%	471,7 k €	-33.6%	709,9 k €	+106%	344 k €	+3.1%	333,6 k €	+11.0%	300,5 k €	+22.7%	244,9 k €	+24.7%	196,4 k €	-44.7%	355 k €	+58.5%	223,9 k €	-19.8%	279,1 k €	+28.8%	216,7 k €	+129%	94,5 k €
Balance sheet
Equity	2 M €	-4.0%	2,1 M €	-22.0%	2,7 M €	+11.6%	2,4 M €	+17.8%	2 M €	-0.6%	2,1 M €	-1.0%	2,1 M €	+16.3%	1,8 M €	+39.5%	1,3 M €	+58.2%	811,1 k €	+29.0%	628,7 k €	-51.1%	1,3 M €	+35.0%	953,4 k €	+46.0%	652,9 k €	-27.8%	903,9 k €	+27.8%	707,5 k €	-38.1%	1,1 M €	+24.3%	919,9 k €	+43.5%	640,8 k €	+51.1%	424,1 k €
Total assets	2,6 M €	-24.3%	3,4 M €	+0.5%	3,4 M €	+4.8%	3,2 M €	+18.0%	2,7 M €	+5.7%	2,6 M €	-6.5%	2,8 M €	+20.0%	2,3 M €	+30.3%	1,8 M €	+16.5%	1,5 M €	-28.8%	2,1 M €	+22.1%	1,7 M €	+28.5%	1,4 M €	+38.1%	979,2 k €	-27.6%	1,4 M €	+19.0%	1,1 M €	-19.6%	1,4 M €	+17.6%	1,2 M €	+30.5%	922,1 k €	+56.6%	589 k €
Cash	825,9 k €	-42.5%	1,4 M €	-11.5%	1,6 M €	+25.8%	1,3 M €	+5.1%	1,2 M €	+18.9%	1 M €	-2.8%	1,1 M €	-25.3%	1,4 M €	+55.4%	914,7 k €	+4.3%	877,4 k €	-41.9%	1,5 M €	+36.2%	1,1 M €	+47.6%	750,9 k €	+38.4%	542,6 k €	-39.4%	895,2 k €	+14.5%	781,8 k €	-27.1%	1,1 M €	+274%	287 k €	-36.2%	450,2 k €	+47.6%	305 k €
Debts	522,7 k €	-58.5%	1,3 M €	+89.1%	666,7 k €	-12.9%	765 k €	+26.2%	606,3 k €	+32.6%	457,3 k €	-13.6%	529,1 k €	+17.4%	450,6 k €	+3.5%	435,2 k €	-33.7%	656,8 k €	-55.3%	1,5 M €	+240%	432,1 k €	+12.6%	383,8 k €	+21.4%	316,2 k €	-28.0%	439,2 k €	+6.4%	412,8 k €	+58.9%	259,7 k €	-3.2%	268,3 k €	-2.6%	275,4 k €	+67.7%	164,3 k €
Other
Workforce	9,7 ETP	+3.2%	9,4 ETP	+27.0%	7,4 ETP	+68.2%	4,4 ETP	-15.4%	5,2 ETP	+15.6%	4,5 ETP	+4.7%	4,3 ETP	+26.5%	3,4 ETP	+9.7%	3,1 ETP	+34.8%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	0.0%	2,3 ETP	+76.9%	1,3 ETP	0.0%	1,3 ETP	+30.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 10 ended

Active mandates

Alphamed Arzneimittel Gmbh & Co Kg

Managing director · since 22 décembre 2025 · until 21 juin 2032

Represented by Friederike Dr. Hrubesch-Mohringer

Active

EurimPharm Vertriebs Gmbh & Co Kg

Director · since 22 décembre 2025 · until 21 juin 2032

Represented by Wolfgang Stallmayer

Active

Magdalena Hrubesch

Director · since 22 décembre 2025 · until 21 juin 2032

Active

Ended mandates

Alphamed Arzneimittel gmbh & Co Kg Venn,

Managing director · since 02 janvier 2021 · until 02 janvier 2027

Represented by Friederika Hrubesch-Mohringer

Ended

Eurim Pharm Vertriebs Gmbh & Co Kg Venn

Director · since 02 janvier 2021 · until 02 janvier 2027

Represented by Wolfgang Stallmayer

Ended

Magdalena Hrubesch

Director · since 02 janvier 2021 · until 02 janvier 2027

Ended

Alphamed Arzneimittel Gmbh & Co Kg Venn.

Managing director · since 20 juin 2005 · until 20 juin 2011

Represented by Andreas Mohringer

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	11/07/2025	29/08/2024	04/08/2023	02/08/2022	30/06/2021
General meeting	15/06/2026	30/06/2025	10/06/2024	12/06/2023	13/06/2022	14/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	15/06/2026	29/06/2026	Dutch	PDF
Abridged model	31/12/2024	30/06/2025	11/07/2025	Dutch	PDF
Full model	31/12/2023	10/06/2024	29/08/2024	Dutch	PDF
Full model	31/12/2022	12/06/2023	04/08/2023	Dutch	PDF
Full model	31/12/2021	13/06/2022	02/08/2022	Dutch	PDF
Full model	31/12/2020	14/06/2021	30/06/2021	Dutch	PDF
Full model	31/12/2019	15/06/2020	23/06/2020	Dutch	PDF
Full model	31/12/2018	17/06/2019	28/06/2019	Dutch	PDF
Full model	31/12/2017	18/06/2018	28/06/2018	Dutch	PDF
Full model	31/12/2016	19/06/2017	30/06/2017	Dutch	PDF
Full model	31/12/2015	14/05/2016	30/06/2016	Dutch	PDF
Full model	31/12/2014	15/06/2015	03/07/2015	Dutch	PDF
Full model	31/12/2013	30/05/2014	30/06/2014	Dutch	PDF
Full model	31/12/2012	17/06/2013	28/06/2013	Dutch	PDF
Full model	31/12/2011	18/06/2012	27/06/2012	Dutch	PDF
Full model	31/12/2010	20/06/2011	29/07/2011	Dutch	PDF
Full model	31/12/2009	21/06/2010	20/07/2010	Dutch	PDF
Full model	31/12/2008	15/06/2009	08/07/2009	Dutch	PDF
Full model	31/12/2007	16/06/2008	03/07/2008	Dutch	PDF
Full modelCorrection	31/12/2006	18/06/2007	18/09/2007	Dutch	PDF
Full model	31/12/2006	18/06/2007	09/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 10 ended

Active mandates

Alphamed Arzneimittel Gmbh & Co Kg

Managing director · since 22 décembre 2025 · until 21 juin 2032

Represented by Friederike Dr. Hrubesch-Mohringer

Active

EurimPharm Vertriebs Gmbh & Co Kg

Director · since 22 décembre 2025 · until 21 juin 2032

Represented by Wolfgang Stallmayer

Active

Magdalena Hrubesch

Director · since 22 décembre 2025 · until 21 juin 2032

Active

Ended mandates

Alphamed Arzneimittel gmbh & Co Kg Venn,

Managing director · since 02 janvier 2021 · until 02 janvier 2027

Represented by Friederika Hrubesch-Mohringer

Ended

Eurim Pharm Vertriebs Gmbh & Co Kg Venn

Director · since 02 janvier 2021 · until 02 janvier 2027

Represented by Wolfgang Stallmayer

Ended

Magdalena Hrubesch

Director · since 02 janvier 2021 · until 02 janvier 2027

Ended

Alphamed Arzneimittel Gmbh & Co Kg Venn.

Managing director · since 20 juin 2005 · until 20 juin 2011

Represented by Andreas Mohringer

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates24/12/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/06/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/05/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/10/2020
ONTSLAGEN - BENOEMINGEN
PDF
Registered office01/08/2019
MAATSCHAPPELIJKE ZETEL
PDF
Mandates12/10/2017
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/09/2015
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-83,4 k €↑
2024
Annual accounts 2024-591,4 k €↓
2023
Annual accounts 2023280,8 k €↓
2022
Annual accounts 2022363,6 k €↓
2021
Annual accounts 2021494,4 k €↓
2020
Annual accounts 2020506,4 k €↑
2019
Annual accounts 2019291 k €↓
2018
Annual accounts 2018507 k €↑
2017
Annual accounts 2017471,7 k €↓
2016
Annual accounts 2016709,9 k €↑
2015
Annual accounts 2015344 k €↑
2014
Annual accounts 2014333,6 k €↑
2013
Annual accounts 2013300,5 k €↑
2012
Annual accounts 2012244,9 k €↑
2011
Annual accounts 2011196,4 k €↓
2010
Annual accounts 2010355 k €↑
2009
Annual accounts 2009223,9 k €↓
2008
Annual accounts 2008279,1 k €↑
2007
Annual accounts 2007216,7 k €↑
2006
Annual accounts 200694,5 k €
02/10/1995
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

MONA LISA

Overview

What does MONA LISA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline